|
|
Immune Modulation Incorporated
The company's legal name is Immune Modulation,
Inc.; (IMI). IMI is a corporation organized for profit and existing under
the laws of the State of Delaware and qualified to transact intrastate
business in the State of California.
Jump to:
Corporate History
Management
Legal Representation
Corporate History
Immune Modulation, Incorporated (IMI) is an
early development stage company conducting research and developing
pharmaceutical drugs in the areas of transplanatation, inflammation,
oncology, and virology.
IMI was formed in 1995 based on the prior research of
Dr. Emmanuel A. Ojo-Amaize.
In 1996 the scope of IMI was expanded to
include natural products from Africa. One such product is hypoestoxide,
which has been found to possess potent anti-angiogenic, anti-viral, and
anti-tumor activities
go to top of page
Management
(click on a name for that person's Bio)
Emmanuel A. Ojo-Amaize, Ph.D.
send a message
Co-founder, President & Chief Executive Officer
Howard B. Cottam, Ph.D.
send a message
Co-founder, Vice President
Emeka J. Nchekwube, M.D.
send a message
Medical Director
Olusola A. Oyemade, M.D., M.P.H.
send a message
Managing Director
Joseph I. Okogun, Ph.D.
Director General, IMI Nigeria, Ltd.
go to top of page
Legal Representation
IMI retains the services of
Pillsbury Winthrop, LLP.
, for
corporate development, intellectual properties, strategic licensing and
partnering transactions.
go to top of page
|
|
Web site designed by
CM Design Concepts
Code & Graphics © 2012 All rights reserved.
|
|
